BloGenoks

Onkogenoks is the brand of Genoks Genetic Diseases Evaluation Center focused on cancer genetics and precision oncology solutions.

The exome refers to all protein-coding regions of the human genome. Although it constitutes only **1–2% of the genome**, more than 85% of known genetic diseases are located within exons. For this reason, exome analysis forms the foundation of modern diagnostic genetic testing.

The exome consists of all protein-coding regions, which make up only 1–2% of the genome. Because the vast majority of genetic diseases originate in these regions, exome analysis has become one of the most critical tools in modern diagnostic genetic testing.

RapidNIPT is a high-accuracy NIPT that screens for 90+ genetic conditions, including Down syndrome, using cfDNA. It is completely risk-free for both the mother and the baby.

RapidNIPT, cfDNA ile Down sendromu dahil 90+ genetik bozukluğu tarar. Anne ve bebek için risksizdir, yüksek doğruluk oranına sahip NIPT testidir.

Onkogenoks, Genoks Genetik Hastalıklar Değerlendirme Merkezi’nin kanser genetiği ve hassas onkoloji çözümlerine odaklanan markasıdır.

The Carrier Screening Test evaluates carrier status for many genetic diseases that are hereditary and mostly autosomal recessive.

RapidNIPT screens for over 90 genetic conditions, including Down syndrome, using cfDNA analysis. It is a non-invasive test that poses no risk to either the mother or the baby and offers a high level of accuracy.